Press Releases

Autoimmune Disease Diagnostics Market Value, Volume, Growth Predictions, and Forecast to 2022-2030

Share This Article

The global autoimmune disease diagnostics market for the historical period 2017–2018 and forecast period 2019–2027, high prevalence of autoimmune diseases across the world, Increased health care expenditure globally, Growing awareness among people about autoimmune diseases are projected to drive the global autoimmune disease diagnostics market during the forecast period

According to the report, the global autoimmune disease diagnostics market was valued at US$ 14.4 Bn in 2018 and is anticipated to expand at a CAGR of 3.8% from 2019 to 2027

Get the sample copy of report@ https://qyresearchmedical.com/sample/111605

High Prevalence of Autoimmune Diseases across the World and Increased Health Care Expenditure Globally: Key Drivers

Rise in the prevalence of autoimmune diseases directly affects the growth and development of the autoimmune disease diagnostics market. The market is estimated to grow at a high rate due to rising incidence of diseases such as systemic lupus erythematosus, rheumatoid arthritis, Hashimoto’s thyroiditis, Graves’ disease, and type 1 diabetes.

According to the National Institutes of Health, up to 23.5 million Americans (more than seven percent of the population) suffer from an autoimmune disease – and the prevalence is rising. The rising prevalence of autoimmune diseases is likely to fuel the growth of the autoimmune disease diagnostics market. Therefore, consistent increase in the autoimmune patient population across the world has been identified as one of the major factors driving the autoimmune disease diagnostics market.

Technological advancements in diagnostic techniques for autoimmune diseases have helped extend the life expectancy of people and led to increased cost of treatment. Governments across the world are increasing their spending to provide better health care services. For instance, an analysis based on preliminary government data by the Centers for Medicare & Medicaid Services revealed that health care spending in the U.S. increased by 5% in 2014 as compared to 3.6% in 2013. Apart from developed countries, health care spending is also rising in developing parts of the world such as India and China. These countries are focusing on providing better health care services to a large population base.

Growing Awareness among People about Autoimmune Diseases Boost Market Growth

Increasing awareness and knowledge about autoimmune diseases among patients and care-givers would significantly contribute to the growth of the autoimmune disease diagnostics market

AARDA initiated the formation of the Center for Autoimmune Disease Research at Johns Hopkins University Medical Center and the NIH established Centers of Excellence in autoimmune diseases. AARDA also sponsors various programs and workshops aimed at bringing together researchers from different disciplines involved in autoimmune research. These factors are likely to fuel the growth of the market.

View full report@ https://qyresearchmedical.com/report/autoimmune-disease-diagnostics-market-test-type-antinuclear-antibody-tests-autoantibody-tests-complete-blood-count-cbc-comprehensive-metabolic-panel-c-reactive-protein-crp-erythrocyte-sedimentation-rate-019-2030/111605

Rising awareness among people and increasing government initiatives are the major factors driving the autoimmune disease diagnostics market

Competitive Pricing and Equipment Costs to Hamper Market

The autoimmune disease diagnostics market is characterized by intense competition from local manufacturers that offer products at low cost. This is expected to hamper market growth as competition could lead to fall in prices of the products.

Moreover, with continuous technological developments in the autoimmune disease diagnostics market with respect to accuracy and efficiency, manufacturers are expected to provide up-to-date solutions to the customers. Customers are in fact hesitant to opt for cost-intensive upgrade procedures as they need to invest more capital for technologically advanced procedures and products.

Therefore, intense competition among players leading to low cost of products and procedures would hamper the growth of the autoimmune disease diagnostics market during the forecast period from 2019 to 2027

Global Autoimmune Disease Diagnostics Market: Competitive Landscape

This report profiles major players in the global autoimmune disease diagnostics market based on various attributes such as company overview, financial overview, product portfolio, business strategies, and recent developments

The global autoimmune disease diagnostics market is highly fragmented, with the presence of a number of international as well as regional players

Leading players operating in the global autoimmune disease diagnostics market are

  • Abbott Laboratories, Inc.,
  • Beckman Coulter, Inc. ,
  • bioMérieux SA,
  • Bio-Rad Laboratories,
  • F. Hoffmann-La, Roche Ltd.,
  • Inova Diagnostics, Inc.,
  • Quest Diagnostics,
  • SQI Diagnostics, Inc.,
  • Siemens Healthcare among others

Global Autoimmune Disease Diagnostics Market: Key Developments

Key players in the global autoimmune disease diagnostics market are engaged in regulatory approvals, technologically advanced products, launch of new products, and acquisition & collaborative agreements with other companies. These strategies are likely to fuel the growth of the global autoimmune disease diagnostics market. A few expansion strategies adopted by players operating in the global autoimmune disease diagnostics market are:

In March 2019, Abbott received CE Mark for its Alinity m diagnostics system and assays. This new technology will help keep up with the growing demand for infectious disease testing.

Purchase Complete Report Now@ https://qyresearchmedical.com/report/checkout/111605/2900

In June 2016, Beckman Coulter Diagnostics announced that it is ramping up its commercial focus on the Indian subcontinent with a series of steps that will help substantially increase its customer base- small- to large-volume hospital pathology laboratories.

In February 2019, Roche have entered into a definitive merger agreement with Spark Therapeutics, Inc. at a price of US$ 114.50 per share in an all-cash transaction.

The report on the global autoimmune disease diagnostics market discussed individual strategies, followed by company profiles of manufacturers of autoimmune disease diagnostics. The competitive landscape section has been included in the report to provide readers with a dashboard view and a company market share analysis of key players operating in the global autoimmune disease diagnostics market.

Key Questions Answered in Global Autoimmune Disease Diagnostics Market Report

  • What is the scope of growth of product companies in the global autoimmune disease diagnostics market?
  • What will be the Y-o-Y growth of the global autoimmune disease diagnostics market between 2019 and 2027?
  • What is the influence of changing trends in technologies on the global autoimmune disease diagnostics market?
  • Will North America continue to be the most profitable market for autoimmune disease diagnostics devices providers?
  • Which factors are anticipated to hamper the growth of the global autoimmune disease diagnostics market during the forecast period?
  • Which are the leading companies in the global autoimmune disease diagnostics market?

Global Autoimmune Disease Diagnostics Market – Segmentation

Test Type

  • Antinuclear Antibody Test
  • Autoantibody Test
  • Complete Blood Count (CBC)
  • Comprehensive Metabolic Panel
  • C-reactive Protein (CRP) Test
  • Erythrocyte Sedimentation Rate (ESR)
  • Urinalysis
  • Others

Disease Type

  • Graves’ Disease
  • Hashimoto’s Thyroiditis
  • Multiple Sclerosis
  • Rheumatoid Arthritis
  • SLE (Lupus)
  • Type 1 Diabetes
  • Others

Region

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa

TABLE OF CONTENT

1. Preface

1.1. Market Definition and Scope

1.2. Market Segmentation

1.3. Key Research Objectives

1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Autoimmune Disease Diagnostics Market

4. Market Overview

4.1. Introduction

4.1.1. Test Type Definition

4.1.2. Industry Evolution / Developments

4.2. Overview

4.3. Market Dynamics

4.3.1. Drivers

4.3.2. Restraints

4.3.3. Opportunities

4.4. Global Autoimmune Disease Diagnostics Market Analysis and Forecast, 2017–2027

4.4.1. Market Revenue Projections (US$ Mn)

5. Key Insights

5.1. Technological Development

5.2. Disease Prevalence & Incidence Cases

6. Global Autoimmune Disease Diagnostics Market Analysis and Forecast, by Test Type

6.1. Introduction & Definition

6.1.1. Key Findings / Developments

6.2. Global Autoimmune Disease Diagnostics Market Value Forecast, by Test Type, 2017–2027

6.2.1. Antinuclear Antibody Test

6.2.2. Autoantibody Test

6.2.3. Complete Blood Count (CBC)

6.2.4. Comprehensive Metabolic Panel

6.2.5. C-reactive Protein (CRP) Test

6.2.6. Erythrocyte Sedimentation Rate (ESR)

6.2.7. Urinalysis

6.2.8. Others

6.3. Global Autoimmune Disease Diagnostics Market Attractiveness, by Test Type

7. Global Autoimmune Disease Diagnostics Market Analysis and Forecast, by Disease Type

7.1. Introduction & Definition

7.1.1. Key Findings / Developments

7.2. Global Autoimmune Disease Diagnostics Market Value Forecast, by Disease Type, 2017–2027

7.2.1. Graves’ Disease

7.2.2. Hashimoto’s Thyroiditis

7.2.3. Multiple Sclerosis

7.2.4. Rheumatoid Arthritis

7.2.5. SLE (Lupus)

7.2.6. Type 1 Diabetes

7.2.7. Others

7.3. Global Autoimmune Disease Diagnostics Market Attractiveness, by Disease Type

8. Global Autoimmune Disease Diagnostics Market Analysis and Forecast, by Region

8.1. Key Findings

8.2. Global Autoimmune Disease Diagnostics Market Value Forecast, by Region

8.2.1. North America

8.2.2. Europe

8.2.3. Asia Pacific

8.2.4. Latin America

8.2.5. Middle East & Africa

8.3. North America Autoimmune Disease Diagnostics Market Attractiveness, by Region

9. North America Autoimmune Disease Diagnostics Market Analysis and Forecast

……..

Purchase Complete Report Now@ https://qyresearchmedical.com/report/checkout/111605/2900

You can place an order or ask any questions, please feel free to contact sales@qyresearchmedical.com | +1 9197 992 333

About Us

QYResearch Medical, focuses on custom research, management consulting, IPO consulting, industry chain research, and data base & seminar services. The company owns large basic databases (such as National Bureau of Statistics Database, Customs Import and Export Database, Industry Association Database, etc.), expert resources (including industry experts who own more than 10 years experiences on marketing or R&D in industries of healthcare services, medical technology & devices, etc.), professional survey team (the team members obtained more than 3 years market survey experience and more than 2 years deep expert interview experience), and excellent data analysis team (SPSS statistics and PPT graphics process team).

QYResearch Medical has more than 4000 global well-known customers, covering more than 30 industries including pharmaceuticals, medical technology & devices, healthcare services etc. Company services cover one-stop solution as Data-Analysis-Suggestion-Consulting Implementation. Research regions cover China, US, EU, Asia, Middle East and Africa, South America, Australia, and other regions in the world.

For Latest Update Follow Us:

https://www.linkedin.com/company/qyresearch-medical/

https://www.facebook.com/QYResearch-Medical-108186514228917/

https://twitter.com/qyresearchmedi

Show More

Related Articles

Back to top button